Cytochrome P450 enzyme (CYP)-associated metabolic studiesin vitrohave been considered cost-effective for predicting potential clinical drug/herb–drug interactions (DDI/HDI).
No takes yet. Share an insight, caveat, or question.
Wang et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: